|
S. no | Cell line (in vitro) | Animals (in vivo) | Mode of cell death | Molecular targets/effects | References |
|
1 | 786-0 (renal cells) | — | Cytotoxicity/apoptosis | NOS↑/BCL2↓ | [27, 70] |
|
2 | 786-0 (renal cells) | — | Cytotoxicity/autophagy | LC3↑/NFκB↓ | [27] |
|
3 | Jurkat T-cells | — | Cytotoxicity/apoptosis |
Caspases 3 and 7↑, oxidative stress, DNA damage RACK1↑ | [81, 82] [80] [70] |
|
4 | HepG2 (hepatoblastoma) Chang (normal cells) | — | Cytotoxicity/apoptosis No toxicity | Caspase-3↑ Sparing normal cells | [72, 73] [72] |
|
5 | HCC (hepatocellular carcinoma) | — | Cytotoxicity/apoptosis | ROS↑ | [85] |
|
6 | Caov-3 (ovarian) Caov-3 (ovarian) MDBK (normal kidney cells) | — | Cytotoxicity/apoptosis Antiproliferative No toxicity | Caspase-3↑ bcl-2↓ and bax↑ Sparing normal cells | [32] [77] [80] |
|
7 | MCF-7, T47D, MDA-MB-231 (breast cancer) | — | Cytotoxicity/apoptosis | Cell cycle arrest/modulating redox status | [33, 89] |
|
8 | MCF-7 (breast cancer) | — | Cytotoxicity/necrosis | Membrane integrity loss | [74] |
|
9 | COR-L23 (large cell lung carcinoma) | — | Cytotoxicity | Good cytotoxic compound to cancer cells | [68] |
|
10 | NCI-H460 (human nonsmall cell lung cancer cells) | — | Cytotoxicity/apoptosis | DNA damage | [86] |
|
11 | Ca9-22 (oral cancer) | — | Cytotoxicity/apoptosis | DNA damage, ROS↑, ΔΨ↓ | [88] |
|
12 | U251 (glioma) | — | Antiproliferative | Good cytotoxic compound to cancer cells | [65] |
|
13 | OVCAR-03 (ovarian) | — | Antiproliferative | Good cytotoxic compound to cancer cells | [65] |
|
14 | PC-3 (prostate) | — | Antiproliferative | Good cytotoxic compound to cancer cells | [65] |
|
15 | W7.2 T-cells | — | Cytotoxicity/apoptosis | DNA damage, RACK1↑ | [70] |
|
16 | NCI-460 (lung, nonsmall cells) | — | Antiproliferative | Good cytotoxic compound to cancer cells | [65] |
|
17 | NSCLC lung cancer | — | Cytotoxicity/apoptosis | DNA damage, MMP-2 and MMP-9↓ | [87] |
|
18 | UACC-62 (melanoma) | — | Antiproliferative | Good cytotoxic compound to cancer cells | [65] |
|
19 | HL-60 (leukemia) | — | Genotoxicity/apoptosis | Ψ↓, caspase-9↑ | [67, 80] [84, 101] |
|
20 | U937 (lymphoma) | — | Cytotoxicity/apoptosis | ΔΨ↓, caspase-9↑ | [84] |
|
21 | CASMC (coronary artery smooth muscle cells) | — | Cytotoxicity/apoptosis | Caspase-2↑, p53↑ | [78, 79] |
|
22 | HeLa (cervical) | — | Cytotoxicity apoptosis | Good cytotoxic compound to cancer cells DNA damage, caspase-9↑ | [80–82] [90] |
|
23 | HGC-27 (gastric) | — | Cytotoxicity | Good cytotoxic compound to cancer cells | [74, 80–82] |
|
24 | 768-0 (kidney) | — | Cytotoxicity | Good cytotoxic compound to cancer cells | [80–82] |
|
25 | HT-29 (colon) LS174T (colon) | — — | Cytotoxicity/apoptosis | Cell cycle arrest at S-phase | [89] [68] |
|
26 | 3T3 (normal fibroblast) ST3 fibroblast | — — | No toxicity Cytotoxicity | Sparing normal cells Kills MMP1 expressing cells | [89] [68] |
|
27 | PANC-1 (pancreatic cancer) | — | Cytotoxicity/necrosis | Loss of cell membrane integrity | [74] |
|
28 | CHO (Chinese hamster ovary) | — | Genotoxicity | Causing damage to DNA | [69] |
|
29 | K562 (chronic myelogenous leukemia) | — | Cytotoxic and anti-inflammatory | NF-κB↓ | [83] |
|
30 | Platelets (rabbits) | — | Inhibitory | Platelet activating factor binding | [31] |
|
31 | Ehrlich tumor cells | Balb/C mice | Cytotoxicity | Tumor regression | [65] |
|
32 | Blood and serum parameters | Long Evans rats | Cytotoxicity | Biochemical/hematology and histopathology evaluation | [47] |
|